Physicochemical characterization of protein-free low density lipoprotein models and influence of drug loading

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 44-51

  Gerke, Astrid ^a   Westesen, Kirsten ^b   Koch, Michel H J ^c  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

LDL; LDL models; NMR; Solvent evaporation; Sunchrotron radiation; X ray solution scattering

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VALRUBICIN; WB 4291;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ELECTRON MICROSCOPY; MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHYSICAL; CHOLESTEROL; CHOLESTEROL ESTERS; DOXORUBICIN; LIPOPROTEINS, LDL; MODELS, CHEMICAL; NITROGEN MUSTARD COMPOUNDS; PARTICLE SIZE; PHOSPHOLIPIDS; PROTEINS; SCATTERING, RADIATION; SYNCHROTRONS; TRIGLYCERIDES;

EID: 0029873069     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016069031411     Document Type: Article

References (21)

1. Shaw, J.M. (Ed.) Lipoproteins as carriers of pharmacological agents, Marcel Dekker, Inc., New York, 1991.
2. R. A. Firestone. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjugate Chem. 5:105-113 (1994).
3. D. P. Via, I. F. Craig, G. W. Jacobs, W. B. Van Winkle, S. C. Charlton, A. M. Gotto Jr., and L. C. Smith. Cholesteryl esterrich microemulsions: stable protein-free analogs of low density lipoproteins. J. Lipid Res., 23:570-576 (1982).
4. G. S. Ginsburg, D. M. Small, and D. Atkinson. Microemulsions of phospholipids and cholesterol esters. J. Biol. Chem., 257:8216-8227 (1982).
5. J. Seki, H. Sasaki, M. Doi, H. Yoshikawa, Y. Takahashi, S. Yamane, H. Fukui, S. Sonoke, H. Yamamoto, M. Hirose, Y. Ezure, T. Ando, K. Ushimaru, and M. Sugiyama. Lipid nanospheres (LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV. J. Controlled Rel., 28:352-353 (1994).
6. M. Peyrot, A. M. Sautereau, J. M. Rabanel, F. Nguyen, J. F. Tocanne, and D. Samain. Supramolecular biovectors (SMBV): a new family of nanoparticulate drug delivery systems. Synthesis and structural characterization. Int. J. Pharm., 102:25-33 (1994).
7. M.D. Owens, and G.H. Halbert. Production and characterization of protein-free analogues of low density lipoproteins. Eur. J. Pharm. Biopharm., 41:120-126 (1995).
8. R. C. Maranhão, B. Garicochea, E. L. Silva, P. D. Llacer, F. J. C. Pileggi, and D. A. F. Chamone. Increased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia: a possible new strategy for the treatment of the disease. Brazilian J. Med. Biol. Res., 25:1003-1007 (1992).
9. B. Sjöström, B. Bergenståhl. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesterol acetate. Int. J. Pharm., 88:53-62 (1992).
10. M. Masquelier, S. Vitols, and C. Peterson. Low-Density Lipoprotein as a Carrier of Antitumoral Drugs: In Vivo Fate of Drug-Human Low-Density Lipoprotein Complexes in Mice. Cancer Res., 46:3842-3847 (1986).
11. F. McNeil-Watson and A. Parker. Comparison of methods of high resolution sub-micron sizing by quasi-elastic light scattering (PCS). In R. A. Williams and N. C. de Jaeger (eds.), Advances in Measurement and Control of Colloidal Processes, Butterworth-Heinemann Ltd.: Oxford, 1991, pp. 421-434.
12. M. H. J. Koch and J. Bordas. X-ray diffraction and scattering on disordered systems using synchrotron radiation. Nucl. Instrum. Methods, 208:461-469 (1983).
13. A. Gabriel and F. Dauvergne. The localisation method used at EMBL. Nucl. Instrum. Methods, 201:223-224 (1982).
14. M. H. J. Koch. Scattering from non-crystalline systems. In H. Ebashi, M. Koch and E. Rubenstein (eds.), Handbook on Synchrotron Radiation; Elsevier Science Publishers, North Holland: Amsterdam, 1991, pp. 241-268.
15. K. Westesen, A. Gerke, and M. H. J. Koch. Characterization of native and drug loaded human low density lipoproteins. J. Pharm. Sci., 84:139-147 (1995).
16. P. A. Kroon. The order-disorder transition of the core cholesteryl esters of human plasma low density lipoprotein. J. Biol. Chem., 256:5332-5339 (1981).
17. R. J. Deckelbaum, G. G. Shipley, D. M. Small, R. S. Lees, and P. K. George. Thermal transitions in human plasma low density lipoproteins. Science, 190:392-394 (1975).
18. R. J. Deckelbaum, G. G. Shipley, and D. M. Small. Structure and interactions of lipids in human plasma low density lipoproteins. J. Biol. Chem., 252:744-754 (1977).
19. P. Laggner, G. Degovics, K. W. Müller, O. Glatter, O. Kratky, G. Kostner, and A. Holasek. Molecular packing and fluidity of lipids in human serum low density lipoproteins. Hoppe-Seyler's Z. Physiol. Chem., 358:771-778 (1977).
20. V. Luzzati, A. Tardieu, and L. P. Aggerbeck. Structure of serum low-density lipoprotein I. A solution X-ray scattering study of a hyperlipidemic monkey low density lipoprotein. J. Mol. Biol., 131:435-473 (1979).
21. B. Siekmann, and K. Westesen. Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur. J. Pharm. Biopharm. (accepted).